ARCHIVES

FDA News: FDA Taking Comments on “First Generic” ANDA Process

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Impetus to Proceed with a March Came From Talk Show

October 31, 1997

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

More Than 300 request RFP for New Community Oncology Program

May 25, 1979